Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CHIMERA: A Phase II Study of Neoadjuvant Pembrolizumab in Combination With Cisplatin or Carboplatin and Pemetrexed Followed by Surgery and Adjuvant Pembrolizumab in Resectable Pleural Mesothelioma.

Clinical lung cancer·2026
Same author

Development of a Radiologic Nomogram to Predict Invasiveness in Pulmonary Pure Ground-Glass Opacities: Analysis of the GORDON Cohort.

Cancers·2026
Same author

Use of a composite, 3D-printed patch as a partial airway replacement: A pilot study on the porcine model.

Bioengineering & translational medicine·2026
Same author

Surgery for Benign Tracheoesophageal Fistula: Analysis of Short- and Long-Term Outcomes.

World journal of surgery·2026
Same author

Video-assisted thoracoscopic surgery as redo approach after prior open lobectomy: is it safely feasible?-challenges and pitfalls of a complex surgical technique.

Journal of visualized surgery·2026
Same author

Editorial: Exploring the tumor microenvironment in resectable lung cancer.

Frontiers in oncology·2026

Related Experiment Video

Updated: Aug 7, 2025

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.5K

Precision Surgery in NSCLC.

Giorgio Cannone1, Giovanni Maria Comacchio1, Giulia Pasello2,3

  • 1Thoracic Surgery Unit, Department of Cardiac, Thoracic Vascular Sciences and Public Health, University Hospital of Padova, 35128 Padova, Italy.

Cancers
|March 11, 2023
PubMed
Summary
This summary is machine-generated.

Precision surgery is revolutionizing non-small cell lung cancer (NSCLC) treatment. Tailoring surgical procedures based on individual molecular and clinical features improves outcomes for advanced NSCLC patients.

Keywords:
NSCLCimmunotherapyprecision surgerytargeted therapy

More Related Videos

Electromagnetic Navigation Transthoracic Nodule Localization for Minimally Invasive Thoracic Surgery
07:30

Electromagnetic Navigation Transthoracic Nodule Localization for Minimally Invasive Thoracic Surgery

Published on: May 4, 2022

3.4K
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

15.8K

Related Experiment Videos

Last Updated: Aug 7, 2025

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.5K
Electromagnetic Navigation Transthoracic Nodule Localization for Minimally Invasive Thoracic Surgery
07:30

Electromagnetic Navigation Transthoracic Nodule Localization for Minimally Invasive Thoracic Surgery

Published on: May 4, 2022

3.4K
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

15.8K

Area of Science:

  • Oncology
  • Thoracic Surgery
  • Molecular Diagnostics

Background:

  • Non-small cell lung cancer (NSCLC) remains a leading cause of cancer death, often diagnosed at advanced stages.
  • Conventional chemotherapy offered limited survival benefits for advanced NSCLC.
  • Recent advancements in understanding tumor molecular alterations and the immune system have transformed treatment paradigms.

Purpose of the Study:

  • To explore the evolving role of surgery in advanced NSCLC.
  • To highlight the principles and benefits of precision surgery in NSCLC.
  • To discuss the integration of multimodality treatments for improved patient outcomes.

Main Methods:

  • Precision surgery involves tailoring surgical decisions based on individual patient clinical stage, molecular, and clinical features.
  • Multimodality treatment strategies incorporate surgery with immune checkpoint inhibitors or targeted agents.
  • Treatment decisions are optimized through a deeper understanding of tumor biology.

Main Results:

  • Advanced NSCLC treatment has been significantly improved by new therapies targeting molecular alterations and the immune system.
  • Surgery is emerging as a valuable rescue therapy in select advanced NSCLC cases.
  • Multimodality treatments in high-volume centers show promising pathologic response and acceptable patient morbidity.

Conclusions:

  • Precision thoracic surgery enables individualized patient selection and treatment strategies for NSCLC.
  • Integrating molecular insights with surgical and systemic therapies offers a paradigm shift in managing NSCLC.
  • The goal is to improve survival and reduce morbidity in patients with non-small cell lung cancer.